APLLTD · Health Care · 2026-08-07

Alembic Pharmaceuticals Ltd

Stage 1 · wk 11In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹830.1
-0.52% today
₹16,317 Cr · Mid cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Visit company website →
P/E (TTM)
22.0
Forward 15.6
Earnings Growth (YoY)
+29.2%
Revenue +4.4%
ROE
+12.4%
Profit margin +9.2%
Dividend Yield
1.45%
P/B 2.6
vs 52W High
-16.4%
₹646.6 lo₹993 hi
16.4% below 52W high — deeper pullback
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 11
1w13w26w
Week 11 — base building
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
3.9%
200 DMA: ₹799 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
1.03x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
→
MA20 flat · -0.4% vs MA50 +2.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 19w
S2 18w
S2 14w
S4 15w
S3 14w
S4 25w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 6w → S2 19w → S3 10w → S2 18w → S3 10w → S2 14w → S3 12w → S4 15w → S1 9w → S2 5w → S3 14w → S4 25w → S1 11w current
Total tracked: 167 weeks across 13 stage runs.
1M
+1.6%
3M
+5.5%
6M
+6.1%
YTD
-1.2%
1Y
-17.6%
Scan Membership
Breakout Watch
Latest: 2025-07-21
3 appearances in last 60 days. First seen: 2024-01-12.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S1
Wk 11 · Vol —x
2026-08-06S1
Wk 11 · Vol —x
2026-08-05S1
Wk 11 · Vol —x
2026-08-04S1
Wk 10 · Vol —x
2026-08-03S1
Wk 10 · Vol —x
2026-07-31S1
Wk 10 · Vol —x
2026-07-30S1
Wk 10 · Vol —x
2026-07-29S1
Wk 10 · Vol —x
2026-07-28S1
Wk 9 · Vol —x
2026-07-27S1
Wk 9 · Vol —x
2026-07-24S1
Wk 9 · Vol —x
2026-07-23S1
Wk 9 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹790.6
200 DMA
₹799
52W High
₹993
52W Low
₹646.6
5D Low
₹805.8
Resistance levels (recent highs)
20d High
₹850.1
60d High
₹850.1
120d High
₹850.1
250d High
₹993
Next resistance
+2.4%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.